MR-guided focused ultrasound (MRgFUS) developer Insightec said that the Japanese Ministry of Health, Labor, and Welfare will provide reimbursement for the use of its Exablate Neuro device in treating Parkinson's disease.
Currently, 12 Exablate Neuro devices routinely are performing MRgFUS for essential tremor. The device received premarket approval for treating Parkinson's disease in January 2020, according to the vendor.